Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
A pharmacogenetic analysis of the Canadian Cancer...
Journal article

A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma

Authors

Han M; Murugesan A; Bahlis NJ; Song K; White D; Chen C; Seftel MD; Howsen-Jan K; Reece D; Stewart K

Journal

Blood, Vol. 128, No. 5, pp. 732–735

Publisher

American Society of Hematology

Publication Date

August 4, 2016

DOI

10.1182/blood-2016-06-716902

ISSN

0006-4971

Associated Experts

Ralph Meyer

Professor Emeritus, Faculty of Health Sciences
Visit profile

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences3211 Oncology and Carcinogenesis3101 Biochemistry and cell biology3201 Cardiovascular medicine and haematology3213 Paediatrics

Medical Subject Headings (MeSH)

Antineoplastic Combined Chemotherapy ProtocolsCanadaGenetic Predisposition to DiseaseHematopoietic Stem Cell TransplantationHumansMaintenance ChemotherapyMelphalanMultiple MyelomaPharmacogenomic TestingPolymorphism, Single NucleotidePrednisoneRandomized Controlled Trials as TopicSurvival AnalysisThalidomideTransplantation, Autologous
View published work (Non-McMaster Users)
View published work (McMaster Users)